ストックスクリーナーアプリを入手
0.3838
0.31%
-0.0012
Nanovibronix Inc (NAOV) 最新ニュース
NanoVibronix files to sell shares of Series G Convertible Preferred Stock, warrants - MSN
Oncolytics Biotech receives Nasdaq non-compliance notice - MSN
NanoVibronix Completes Merger with ENvue Medical Holdings - TipRanks
NanoVibronix Acquires ENvue Medical Holdings To Expand Medical Device Market Reach - Nasdaq
FDA Approves MED-EL’s Sonnet 3 Audio Processor for Cochlear Implants - MPO-mag
NanoVibronix Acquires Enteral Feeding Company ENvue - MPO-mag
NanoVibronix Acquires ENvue Medical Holdings - citybiz
NanoVibronix Completes ENvue Medical Acquisition -February 14, 2025 at 10:54 am EST - Marketscreener.com
NanoVibronix acquires enteral tech firm ENvue Medical - Investing.com
NanoVibronix completes acquisition of ENvue Medical - TipRanks
NanoVibronix acquires enteral tech firm ENvue Medical By Investing.com - Investing.com UK
Strategic Medical Tech Acquisition: NanoVibronix Takes Over Enteral Feeding Pioneer ENvue - StockTitan
Ascendis Pharma targets €200M SKYTROFA revenue and expands YORVIPATH globally in 2025 - MSN
Ocean Biomedical reports unregistered equity sales - MSN
IMUNON names Douglas Faller as chief medical officer - MSN
Pilot Phase Ends for NanoVibronix’s UroShield Study - MPO-mag
NanoVibronix Provides Year-End Business Update - ACCESS Newswire
NanoVibronix Announces Presentation of PainShield(R) to HCPCS Workgroup at CMS - ACCESS Newswire
NAOV’s 2023 Market Dance: Down -23.05% – Time to Invest? - The InvestChronicle
In the Green: MKDWELL Tech Inc (MKDW) Closes at 0.37, Up/Down -20.43 from Previous Day - The Dwinnex
Market Insights: Oncology Institute Inc (TOI)’s Notable Drop of -3.75, Closing at 0.85 - The Dwinnex
Daily Market Movement: NanoVibronix Inc (NAOV) Sees a -5.63 Decrease, Closing at 0.45 - The Dwinnex
Closing Bell Recap: FMC Corp (FMC) Ends at 35.92, Reflecting a -33.53 Downturn - The Dwinnex
EyePoint stock jumps 10% on Duravyu study results - MSN
Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com
Whirlpool Corp (WHR) Shares Rise Despite Market Challenges - The News Heater
BBB Foods Inc (TBBB) Stock Price and Analyst Predictions - The News Heater
NAOV’s price-to-free cash flow ratio: A closer look at its relevance - US Post News
NanoVibronix Inc (NAOV) is looking forward to a strong quarter - SETE News
Pre-market Movers: SLGL, VIRX, ANVS, CUTR... - RTTNews
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NanoVibronix Secures $12M Minimum Purchase Commitment for PainShield - MPO-mag
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield(R) and UroShield(R) in Italy - ACCESS Newswire
NanoVibronix stock touches 52-week low at $0.44 amid market challenges - MSN
NanoVibronix stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
NanoVibronix’s UroShield trial results hold potential to advance urinary care: GlobalData - Express Healthcare
NanoVibronix stock touches 52-week low at $0.46 amid market challenges - Investing.com Canada
NanoVibronix stock touches 52-week low at $0.46 amid market challenges By Investing.com - Investing.com South Africa
Septerna (NASDAQ: SEPN) Appoints Gil Labrucherie as Chief Financial Officer - Defense World
NanoVibronix (NASDAQ:NAOV) Enters into Securities Exchange AgreementOn January 7, 2025, NanoVibronix, Inc. filed an 8-K form with the Securities and Exchange Commission, disclosing its recent agreement with an institutional investor. The company en - Defense World
NanoVibronix advances medical device development By Investing.com - Investing.com Canada
NanoVibronix announces exchange agreement with investor By Investing.com - Investing.com
NanoVibronix advances medical device development - Investing.com
NanoVibronix Unveils Next-Gen PainShield and UroShield with Enhanced Therapy Features - StockTitan
Transforming catheter care: NanoVibronix completes successful UroShield US trial - Yahoo Finance
NanoVibronix Announces Completion of Pilot Phase of UroShield® Clinical Study at University of MichiganOn January 6, 2025, NanoVibronix Inc. (NASDAQ: NAOV) revealed the successful conclusion of the initial phase of a Randomized Control Trial study at - Defense World
NanoVibronix Advances UroShield® Trial and Receives Nasdaq Extension - TipRanks
NanoVibronix completes pilot study of UroShield - Mass Device
NanoVibronix “achieves goals” of US trial pilot phase with UroShield - Yahoo Finance
NanoVibronix, Inc. Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan - Marketscreener.com
NanoVibronix's UroShield Completes Key Clinical Trial Phase at University of Michigan - StockTitan
NanoVibronix (NASDAQ: NAOV) Shares Key Insights from Annual Stockholder Meeting - Defense World
NanoVibronix Presents at Annual Stockholders Meeting - TipRanks
1.16%
0.10%
大文字化:
|
ボリューム (24 時間):